State Street Corp Adicet Bio, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Adicet Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 229,721 shares of ACET stock, worth $204,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares
229,721
Previous 244,821 6.17%
Holding current value
$204,451
Previous $296,000 11.49%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.07 - $1.63 $16,157 - $24,613
-15,100 Reduced 6.17%
229,721 $330,000
Q2 2024

Aug 14, 2024
SELL
$1.21 - $2.4 $841,449 - $1.67 Million
-695,413 Reduced 73.96%
244,821 $296,000
Q1 2024

May 15, 2024
BUY
$1.76 - $3.45 $527,456 - $1.03 Million
299,691 Added 46.79%
940,234 $2.21 Million
Q4 2023

Feb 14, 2024
BUY
$1.11 - $1.89 $7,781 - $13,248
7,010 Added 1.11%
640,543 $1.21 Million
Q3 2023

Nov 14, 2023
BUY
$1.37 - $3.4 $95,583 - $237,214
69,769 Added 12.38%
633,533 $867,000
Q2 2023

Aug 14, 2023
SELL
$2.13 - $7.13 $1,476 - $4,941
-693 Reduced 0.12%
563,764 $1.37 Million
Q1 2023

May 15, 2023
SELL
$5.52 - $9.23 $9.5 Million - $15.9 Million
-1,720,129 Reduced 75.29%
564,457 $3.25 Million
Q4 2022

Feb 14, 2023
BUY
$7.72 - $21.27 $2.52 Million - $6.94 Million
326,321 Added 16.66%
2,284,586 $20.4 Million
Q3 2022

Nov 15, 2022
BUY
$13.43 - $18.74 $19.9 Million - $27.8 Million
1,482,409 Added 311.52%
1,958,265 $27.8 Million
Q2 2022

Aug 15, 2022
BUY
$10.26 - $20.81 $811,442 - $1.65 Million
79,088 Added 19.93%
475,856 $6.95 Million
Q1 2022

May 16, 2022
BUY
$11.53 - $19.97 $799,340 - $1.38 Million
69,327 Added 21.17%
396,768 $7.92 Million
Q4 2021

Feb 14, 2022
BUY
$7.37 - $17.49 $229,899 - $545,583
31,194 Added 10.53%
327,441 $5.73 Million
Q3 2021

Nov 15, 2021
BUY
$6.29 - $9.93 $283,364 - $447,346
45,050 Added 17.93%
296,247 $2.32 Million
Q2 2021

Aug 16, 2021
BUY
$9.19 - $15.93 $2.21 Million - $3.83 Million
240,687 Added 2290.08%
251,197 $2.59 Million
Q1 2021

May 17, 2021
SELL
$12.12 - $17.17 $60,066 - $85,094
-4,956 Reduced 32.04%
10,510 $137,000
Q3 2020

Nov 10, 2020
BUY
$10.18 - $21.4 $157,443 - $330,972
15,466 New
15,466 $184,000

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $35.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email